ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
Drug candidateTypeMolecular formulaPubChem CID Canonical
Molecular Weight
2
(+)-7,7-Bis[(5R,7R,9R,10S)-2-Oxocadinan-3,6(11)-Dien-12,7-Olide]
Potential inhibitor of SARS-CoV-2 protein targets
C30H34O625016667
CC1CC2(C(=C(C(=O)O2)C)C3C1CC(=O)C(=C3)C)C45CC(C6CC(=O)C(=CC6C4=C(C(=O)O5)C)C)C
490.6
3
(+)-Oxoturkiyenine
Potential inhibitor of SARS-CoV-2 protein targets
C20H13NO7189308
CN1C=CC2=CC3=C(C=C2C(=O)C14C5=C(C6=C(C=C5)OCO6)OC4=O)OCO3
379.3
4
(2S)-Eriodictyol-7-O-(6"-O-galloyl)-beta-D-glucopyranoside
Potential inhibitor of SARS-CoV-2 protein targets
C28H26O1510930068
C1C(OC2=CC(=CC(=C2C1=O)O)OC3C(C(C(C(O3)COC(=O)C4=CC(=C(C(=C4)O)O)O)O)O)O)C5=CC(=C(C=C5)O)O
602.5
5
1,3,4,6-tetra-O-galloyl-β-d-glucose
The in vitro activity of 1,3,4,6-tetra-O-galloyl-β-d-glucose against herpes simplex virus has been examined
C34H28O22471531
C1=C(C=C(C(=C1O)O)O)C(=O)OCC2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5)O)O)O
788.6
6
18-Hydroxy-3-epi-alpha-yohimbine
Potential inhibitor of SARS-CoV-2 protein targets
C21H26N2O4102004710
COC(=O)C1C2CC3C4=C(CCN3CC2CC(C1O)O)C5=CC=CC=C5N4
370.4
7
2-(3,4-dihydroxyphenyl)-2-[[2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl]oxy]-3,4-dihydro-2H-1-benzopyran-3,4,5,7-tetrol) - Procyanidin
Potential inhibitor of SARS-CoV-2 protein targets
C30H26O13107876
C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC4(C(C(C5=C(C=C(C=C5O4)O)O)O)O)C6=CC(=C(C=C6)O)O
594.5
8
2-Hydroxy-3-methoxystrychnine
Potential inhibitor of SARS-CoV-2 protein targets
C22H24N2O421680050
COC1=C(C=C2C(=C1)N3C4C25CCN6C5CC7C4C(CC3=O)OCC=C7C6)O
380.4
9
3,5,7,3',4',5'-hexahydroxyflavanone-3-O-beta-D-glucopyranoside
Potential inhibitor of SARS-CoV-2 protein targets
C20H19NO11NPACT00105
c1c(cc(c2c1O[C@@H]([C@H](C2=O)ON[C@@H](CCC(=O)O)C=O)c1cc(c(c(c1)O)O)O)O)O
449.4
10
3Alpha,17Alpha-Cinchophylline
Potential inhibitor of SARS-CoV-2 protein targets
C30H34N4O76326662
COC1=CC=CC2=C1C3=C(N2)C(NCC3)CC4CC5C6=C(CCN5CC4C=C)C7=CC=CC=C7N6
466.6
11
4-(3,4-Dihydroxyphenyl)-7-methoxy-5-[(6-O-β-D-xylopyranosyl-β-D-glucopyranosyl)oxy]-2H-1-benzopyran-2-one
Potential inhibitor of SARS-CoV-2 protein targets
C27H30O15117065340
COC1=CC2=C(C(=CC(=O)O2)C3=CC(=C(C=C3)O)O)C(=C1)OC4C(C(C(C(O4)COC5C(C(C(CO5)O)O)O)O)O)O
594.5
12
4-hydroxyisolonchocarpin
Potential inhibitor of SARS-CoV-2 protein targets
C20H18O45321800
CC1(C=CC2=CC(=C(C=C2O1)O)C(=O)C=CC3=CC=C(C=C3)O)C
322.4
13
4'-O-methylbavachalcone
Potential inhibitor of SARS-CoV-2 protein targets
C22H24O442607530
CC(=CCC1=CC(=C(C=C1OC)O)C(=O)C=CC2=CC=C(C=C2)OC)C
352.4
14
5,7,3',4'-Tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone
Potential inhibitor of SARS-CoV-2 protein targets
C20H18O611610052
CC(=CCC1=C(C=CC(=C1O)O)C2=COC3=CC(=CC(=C3C2=O)O)O)C
354.4
15
5-amino levulinic acid
A naturally synthesised amino acid that potently inhibited SARS-CoV-2 infection in vitro
C5H9NO3137C(CC(=O)O)C(=O)CN131.1
16
7-Deacetyl-7-benzoylgedunin
Potential inhibitor of SARS-CoV-2 protein targets
C33H36O752952112
CC1(C2CC(C3(C(C2(C=CC1=O)C)CCC4(C35C(O5)C(=O)OC4C6=COC=C6)C)C)OC(=O)C7=CC=CC=C7)C
544.6
17
Acteoside
Potential inhibitor of SARS-CoV-2 protein targets
C29H36O155281800
CC1C(C(C(C(O1)OC2C(C(OC(C2OC(=O)C=CC3=CC(=C(C=C3)O)O)CO)OCCC4=CC(=C(C=C4)O)O)O)O)O)O
624.6
18
Adlumidine
Potential inhibitor of SARS-CoV-2 protein targets
C20H17NO6120734
CN1CCC2=CC3=C(C=C2C1C4C5=C(C6=C(C=C5)OCO6)C(=O)O4)OCO3
367.4
19
Alantolactone
Displayed antiviral effects against SARS-CoV-2 in a cytopathic effect-based high throughput screening assay
C15H20O272724
CC1CCCC2(C1=CC3C(C2)OC(=O)C3=C)C
232.3
20
Allicin
An organosulfur compound that may have immunomodulatory and antiviral effects
C6H10OS265036C=CCSS(=O)CC=C162.3
21
Alloyohimbine
Potential inhibitor of SARS-CoV-2 protein targets
C21H26N2O3120716
COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O
354.4
22
alpha-Colubrine
Potential inhibitor of SARS-CoV-2 protein targets
C22H24N2O312303796
COC1=CC2=C(C=C1)C34CCN5C3CC6C7C4N2C(=O)CC7OCC=C6C5
364.4
23
Amaranthin
Potential inhibitor of SARS-CoV-2 protein targets
C30H34N2O196123095
C1C(NC(=CC1=CC=[N+]2C(CC3=CC(=C(C=C32)O)OC4C(C(C(C(O4)CO)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C(=O)[O-])C(=O)O)C(=O)O
726.6
24
Amarogentin
Potential inhibitor of SARS-CoV-2 protein targets
C29H30O13115149
C=CC1C2CCOC(=O)C2=COC1OC3C(C(C(C(O3)CO)O)O)OC(=O)C4=C(C=C(C=C4O)O)C5=CC(=CC=C5)O
586.5
25
Amentoflavone
Potential inhibitor of SARS-CoV-2 protein targets
C30H18O105281600
C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)C4=C(C=CC(=C4)C5=CC(=O)C6=C(C=C(C=C6O5)O)O)O)O
538.5
26
Anabsinthin
Potential inhibitor of SARS-CoV-2 protein targets
C30H40O644558930
CC1C2CCC(C3C4C5CC6(C7(C4C(=C3C2OC1=O)C)C5C(O6)(CCC8C7OC(=O)C8C)C)C)(C)O
496.6
27
Anaferine
Potential inhibitor of SARS-CoV-2 protein targets
C13H24N2O443143C1CCNC(C1)CC(=O)CC2CCCCN2224.3
28
Andrographolide
Potential inhibitor of SARS-CoV-2 protein targets
C20H30O55318517
CC12CCC(C(C1CCC(=C)C2CC=C3C(COC3=O)O)(C)CO)O
350.4
29
Anisotine
Potential inhibitor of SARS-CoV-2 protein targets
C20H19N3O3442884
CNC1=C(C=C(C=C1)C2CCN3C2=NC4=CC=CC=C4C3=O)C(=O)OC
349.4
30
Anthraquinone
Potential inhibitor of SARS-CoV-2 protein targets
C14H8O26780
C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3C2=O
208.2
31
Antroquinonol
Its safety and efficacy in the treatment of mild to moderate pneumonia as a result of COVID-19 is being investigated
C24H38O424875259
CC1C(C(C(=C(C1=O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)C
390.6
32
Apigenin
A flavonoid with potential antiviral, antioxidant and anti-inflammatory activity
C15H10O55280443
C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O
270.2
33
Ararobinol
Potential inhibitor of SARS-CoV-2 protein targets
C30H22O6438692
CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2C4C5=C(C(=CC=C5)O)C(=O)C6=C4C=C(C=C6O)C)C=CC=C3O
478.5
34
Arctigenin
Its therapeutic efficacy against several viruses has been previously investigated
C21H24O664981
COC1=C(C=C(C=C1)CC2COC(=O)C2CC3=CC(=C(C=C3)O)OC)OC
372.4
35
Arjunic acid
Potential inhibitor of SARS-CoV-2 protein targets
C30H48O515385516
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1O)C)C(=O)O)C
488.7
36
Asparagamine A
Potential inhibitor of SARS-CoV-2 protein targets
C22H27NO5
ChemSpider ID: 10269744
C[C@H]1/C(O[C@@]23O[C@H]4[C@]5(/C=C/CC)[N@@](CC[C@H]35)[C@H](C4)[C@@H]21)=C6OC(C(C)=C/6OC)=O
385.5
37
Baicalein
An aglycone of baicalin that may have inhibitory activity against SARS-CoV-2
C15H10O55281605
C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C(=C3O)O)O
270.2
38
Baicalin
May have inhibitory activity against SARS-CoV-2
C21H18O1164982
C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)C(=O)O)O)O)O)O)O
446.4
39
Bavachin
Displayed antiviral effects against SARS-CoV-2 in a cytopathic effect-based high throughput screening assay
C20H20O414236566
CC(=CCC1=CC2=C(C=C1O)OC(CC2=O)C3=CC=C(C=C3)O)C
324.4
40
Benzquercin
Flavonoid compound that has been screened against the SARS-CoV-2 RNA dependent RNA polymerase
C50H40O765604
C1=CC=C(C=C1)COC2=C(C=C(C=C2)C3=C(C(=O)C4=C(O3)C=C(C=C4OCC5=CC=CC=C5)OCC6=CC=CC=C6)OCC7=CC=CC=C7)OCC8=CC=CC=C8
752.8
41
Berberine
Potential inhibitor of SARS-CoV-2 protein targets
C20H18NO4+2353
COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC
336.4
42
Betulinic acid
May be a potential small molecule inhibitor of SARS-CoV-2 protein targets
C30H48O364971
CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)C(=O)O
456.7
43
Biflavone
Potential inhibitor of SARS-CoV-2 protein targets
C30H18O49980790
C1=CC=C(C=C1)C2=C(C(=O)C3=CC=CC=C3O2)C4=C(OC5=CC=CC=C5C4=O)C6=CC=CC=C6
442.5
44
Bisdemethoxycurcumin
A curcuminoid with antioxidant, antiviral and anti-inflammatory properties
C19H16O45315472
C1=CC(=CC=C1C=CC(=O)CC(=O)C=CC2=CC=C(C=C2)O)O
308.3
45
Broussochalcone A
Potential inhibitor of SARS-CoV-2 protein targets
C20H20O56438825
CC(=CCC1=CC(=C(C=C1O)O)C(=O)C=CC2=CC(=C(C=C2)O)O)C
340.4
46
Bruceine A
Displayed antiviral effects against SARS-CoV-2 in a cytopathic effect-based high throughput screening assay
C26H34O11160006
CC1=C(C(=O)CC2(C1CC3C45C2C(C(C(C4C(C(=O)O3)OC(=O)CC(C)C)(OC5)C(=O)OC)O)O)C)O
522.5
47
Brusatol
Displayed antiviral effects against SARS-CoV-2 in a cytopathic effect-based high throughput screening assay
C26H32O1173432
CC1=C(C(=O)CC2(C1CC3C45C2C(C(C(C4C(C(=O)O3)OC(=O)C=C(C)C)(OC5)C(=O)OC)O)O)C)O
520.5
48
Bufalin
Displayed antiviral effects against SARS-CoV-2 in a cytopathic effect-based high throughput screening assay
C24H34O49547215
CC12CCC(CC1CCC3C2CCC4(C3(CCC4C5=COC(=O)C=C5)O)C)O
386.5
49
Bufotaline
Displayed antiviral effects against SARS-CoV-2 in a cytopathic effect-based high throughput screening assay
C26H36O612302120
CC(=O)OC1CC2(C3CCC4CC(CCC4(C3CCC2(C1C5=COC(=O)C=C5)C)C)O)O
444.6
50
Cadambine
Potential inhibitor of SARS-CoV-2 protein targets
C27H32N2O1021723831
COC(=O)C1=COC(C2C1CC34C5=C(CCN3CC2O4)C6=CC=CC=C6N5)OC7C(C(C(C(O7)CO)O)O)O
544.5
51
Caffeic acid phenethyl ester - Propolis (from bees)
Antiviral and anti-inflammatory properties - a potential inhibitor of SARS-CoV-2 protein targets
C17H16O45281787
C1=CC=C(C=C1)CCOC(=O)C=CC2=CC(=C(C=C2)O)O
284.3
52
Calceolarioside B
Potential inhibitor of SARS-CoV-2 protein targets
C23H26O115273567
C1=CC(=C(C=C1CCOC2C(C(C(C(O2)COC(=O)C=CC3=CC(=C(C=C3)O)O)O)O)O)O)O
478.4
53
Calendoflaside
Potential inhibitor of SARS-CoV-2 protein targets
C28H32O1514238620
CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)OC)C)O)O)O)O)O
608.5
54
Camphor
Potential inhibitor of SARS-CoV-2 protein targets
C10H16O2537CC1(C2CCC1(C(=O)C2)C)C152.2
55
Camptothecin
Potential inhibitor of SARS-CoV-2 protein targets
C20H16N2O424360
CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O
348.4
56
Cannabidiol
A compound from Cannabis sativa that has anti-inflammatory properties and could be used for the treatment of COVID-19
C21H30O2644019
CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O
314.5
57
Cannabigerol
A compound from Cannabis sativa that has anti-inflammatory properties and could be used for the treatment of COVID-19
C21H32O25315659
CCCCCC1=CC(=C(C(=C1)O)CC=C(C)CCC=C(C)C)O
316.5
58
Carvacrol
Potential inhibitor of SARS-CoV-2 protein targets
C10H14O10364CC1=C(C=C(C=C1)C(C)C)O150.2
59
Castalagin
The antiviral properties of castalagin against herpes simplex virus has been investigated
C41H26O26
168165 (ChemSpider: 62895210)
C1C2C(C3C4C(C5=C(C(=C(C(=C5C(=O)O4)C6=C(C(=C(C(=C6C(=O)O3)C7=C(C(=C(C=C7C(=O)O2)O)O)O)O)O)O)O)O)O)O)OC(=O)C8=CC(=C(C(=C8C9=C(C(=C(C=C9C(=O)O1)O)O)O)O)O)O
934.6
60
Catechin
Potential inhibitor of SARS-CoV-2 protein targets
C15H14O69064
C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O
290.3
61
Cepharanthine
Displayed antiviral effects against SARS-CoV-2 in a cytopathic effect-based high throughput screening assay
C37H38N2O610206
CN1CCC2=CC3=C(C4=C2C1CC5=CC=C(C=C5)OC6=C(C=CC(=C6)CC7C8=CC(=C(C=C8CCN7C)OC)O4)OC)OCO3
606.7
62
Chebulagic acid
A natural compound that has antiviral activity against SARS-CoV-2, including the main protease
C41H30O27
250397 (ChemSpider: 391031)
C1C2C3C(C(C(O2)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C6=C5C(C(C(=O)O3)CC(=O)O)C(C(=O)O6)O)O)O)OC(=O)C7=CC(=C(C(=C7C8=C(C(=C(C=C8C(=O)O1)O)O)O)O)O)O
954.7
63
Cholecalciferol
May reduce the odds of of developing respiratory infections
C27H44O5280795
CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C
384.6
64
Chrysin
Antiviral and anti-inflammatory properties - a potential inhibitor of SARS-CoV-2 protein targets
C15H10O45281607
C1=CC=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O
254.2
65
Cinobufagin
Displayed antiviral effects against SARS-CoV-2 in a cytopathic effect-based high throughput screening assay
C26H34O611969542
CC(=O)OC1C(C2(CCC3C(C24C1O4)CCC5C3(CCC(C5)O)C)C)C6=COC(=O)C=C6
442.5
66
Clemastanin B
A lignan that has activity against viruses, including human and avian influenza viruses
C32H44O1610009802
COC1=C(C=CC(=C1)CC2COC(C2CO)C3=CC(=C(C=C3)OC4C(C(C(C(O4)CO)O)O)O)OC)OC5C(C(C(C(O5)CO)O)O)O
684.7
67
Colchicine
An alkaloid that has anti-inflammatory activity and may be used as a potential treatment for COVID-19
C22H25NO66167
CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC
399.4
68
Colistin
Potential inhibitor of SARS-CoV-2 protein targets
C52H98N16O135311054
CCC(C)CCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)C(C)O
1155.4
69
Coniferyl aldehyde
Displayed antiviral effects against SARS-CoV-2 in a cytopathic effect-based high throughput screening assay
C10H10O35280536COC1=C(C=CC(=C1)C=CC=O)O178.2
70
Cordifolioside A
Potential inhibitor of SARS-CoV-2 protein targets
C22H32O1375111036
COC1=CC(=CC(=C1OC2C(C(C(C(O2)CO)O)OC3C(C(CO3)(CO)O)O)O)OC)C=CCO
504.5
71
Corilagin
A polyphenol that could potentially inhibit SARS-CoV-2 viral entry and replication
C27H22O1873568
C1C2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)O)OC(=O)C4=CC(=C(C(=C4C5=C(C(=C(C=C5C(=O)O1)O)O)O)O)O)O)O
634.5
72
Cornuside
Displayed antiviral effects against SARS-CoV-2 in a cytopathic effect-based high throughput screening assay
C24H30O1411228694
COC(=O)C1=COC(C(C1CCOC(=O)C2=CC(=C(C(=C2)O)O)O)C=C)OC3C(C(C(C(O3)CO)O)O)O
542.5
73
Corosolic acid
Potential inhibitor of SARS-CoV-2 protein targets
C30H48O46918774
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1C)C)C(=O)O
472.7
74
Crocetin
A natural compound that may have antiviral properties
C20H24O45281232
CC(=CC=CC=C(C)C=CC=C(C)C(=O)O)C=CC=C(C)C(=O)O
328.4
75
Cryptotanshinone
Displayed antiviral effects against SARS-CoV-2 in a cytopathic effect-based high throughput screening assay
C19H20O3160254
CC1COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C
296.4
76
Curcumin
A natural compound that could be used to modulate the immune response (suppress inflammation)
C21H20O6969516
COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O
368.4
77
Cyanidin-3-O-glucoside
Potential inhibitor of SARS-CoV-2 protein targets
C21H21O11+4481259
C1=CC(=C(C=C1C2=[O+]C3=CC(=CC(=C3C=C2OC4C(C(C(C(O4)CO)O)O)O)O)O)O)O
449.4
78
Cyclocurcumin
Potential inhibitor of SARS-CoV-2 protein targets
C21H20O669879809
COC1=C(C=CC(=C1)C=CC2=CC(=O)CC(O2)C3=CC(=C(C=C3)O)OC)O
368.4
79
Dehydrocostus lactone
Displayed antiviral effects against SARS-CoV-2 in a cytopathic effect-based high throughput screening assay
C15H18O273174
C=C1CCC2C(C3C1CCC3=C)OC(=O)C2=C
230.3
80
Dehydrodiisoeugenol
Displayed antiviral effects against SARS-CoV-2 in a cytopathic effect-based high throughput screening assay
C20H22O45379033
CC=CC1=CC2=C(C(=C1)OC)OC(C2C)C3=CC(=C(C=C3)O)OC
326.4
81
Demethoxycurcumin
A curcuminoid with antioxidant, antiviral and anti-inflammatory properties
C20H18O55469424
COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC=C(C=C2)O)O
338.4
82
Digoxin
Displayed antiviral effects against SARS-CoV-2 in a cytopathic effect-based high throughput screening assay
C41H64O142724385
CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
780.9
83
Edgeworoside C
Potential inhibitor of SARS-CoV-2 protein targets
C24H20O10101835682
CC1C(C(C(C(O1)OC2=C(C3=C(C=C2)C=CC(=O)O3)C4=C(C=CC5=C4OC(=O)C=C5)O)O)O)O
468.4
84
Egenine
Potential inhibitor of SARS-CoV-2 protein targets
C20H19NO6189685
CN1CCC2=CC3=C(C=C2C1C4C5=C(C(O4)O)C6=C(C=C5)OCO6)OCO3
369.4
85
Eicosapentaenoic acid
A free fatty acid that could be used to manage the cytokine storm in COVID-19
C20H30O2446284
CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O
302.5
86
Ellagic acid
Potential inhibitor of SARS-CoV-2 protein targets
C14H6O85281855
C1=C2C3=C(C(=C1O)O)OC(=O)C4=CC(=C(C(=C43)OC2=O)O)O
302.2
87
Ellipticine
Potential inhibitor of SARS-CoV-2 protein targets
C17H14N23213
CC1=C2C=CN=CC2=C(C3=C1NC4=CC=CC=C43)C
246.3
88
Emetine
The ability of emetine to inhibit SARS-CoV-2 in vitro and its pharmacokinetic properties in vivo have been investigated
C29H40N2O410219
CCC1CN2CCC3=CC(=C(C=C3C2CC1CC4C5=CC(=C(C=C5CCN4)OC)OC)OC)OC
480.6
89
Emodin
Potential inhibitor of SARS-CoV-2 protein targets
C15H10O53220
CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O)O
270.2
90
Epicatechin gallate
Potential inhibitor of SARS-CoV-2 protein targets
C22H18O10107905
C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O
442.4
91
Epigallocatechin
Potential inhibitor of SARS-CoV-2 protein targets
C15H14O772277
C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)O
306.3
92
Epigallocatechin gallate
Potential inhibitor of SARS-CoV-2 protein targets
C22H18O1165064
C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O
458.4
93
Epsilon-viniferin
Potential inhibitor of SARS-CoV-2 protein targets
C28H22O65281728
C1=CC(=CC=C1C=CC2=C3C(C(OC3=CC(=C2)O)C4=CC=C(C=C4)O)C5=CC(=CC(=C5)O)O)O
454.5
94
Euscaphic acid
Potential inhibitor of SARS-CoV-2 protein targets
C30H48O5471426
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1(C)O)C)C(=O)O
488.7
95
Fangchinoline
Displayed antiviral effects against SARS-CoV-2 in a cytopathic effect-based high throughput screening assay
C37H40N2O673481
CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=C(O3)C(=C(C=C7CCN6C)OC)O)OC)OC
608.7
96
Fisetin
A bioactive flavonol compound that may be used in the management of COVID-19
C15H10O65281614
C1=CC(=C(C=C1C2=C(C(=O)C3=C(O2)C=C(C=C3)O)O)O)O
286.2
97
Folic acid
Potential inhibitor of SARS-CoV-2 protein targets
C19H19N7O6135398658
C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N
441.4
98
Friedelin
Potential inhibitor of SARS-CoV-2 protein targets
C30H50O91472
CC1C(=O)CCC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C)C)C)C)C)C
426.7
99
Galangin
Antiviral and anti-inflammatory properties - a potential inhibitor of SARS-CoV-2 protein targets
C15H10O55281616
C1=CC=C(C=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O
270.2
100
Gallocatechin gallate
Potential inhibitor of SARS-CoV-2 protein targets
C22H18O11199472
C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O
458.4